OR WAIT 15 SECS
© 2020 MJH Life Sciences and Contemporary Pediatrics. All rights reserved.
© 2020 MJH Life Sciences™ and Contemporary Pediatrics. All rights reserved.
July 24, 2020
Atopic dermatitis treatment has dramatically changed over the years. Here’s a look at the current options.
May 26, 2020
The US Food and Drug Administration has approved dupilumab (Dupixent, Sanofi and Regeneron) for the treatment of moderate-to-severe atopic dermatitis in children aged 6 to 11 years.
February 06, 2020
Postpartum depression has a number of profound effects. A new study indicates that postpartum depression could increase the risk of atopic dermatitis, especially at ages 5 and 9 years.